Assets 更改
AbbVie USD 136.22B 854M 2023-09
Abbott USD 73.35B 440M 2023-06
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Baxter International USD 28.28B 2.38B 2023-12
Bayer EUR 117.24B 4.43B 2023-09
Becton, Dickinson and Co. USD 52.27B 506M 2023-12
Biogen USD 26.84B 1.35B 2023-12
Boston Scientific USD 34.04B 442M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
CONMED USD 2.33B 2.95M 2023-09
Cooper Companies USD 12.03B 373.7M 2023-12
Dexcom USD 6.26B 331.7M 2023-12
Edwards Lifesciences USD 9.36B 7.6M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Globus Medical USD 5.09B 269.79M 2023-12
Hologic USD 8.47B 669.8M 2023-12
Insulet USD 2.59B 120.5M 2023-12
Integra LifeSciences USD 3.78B 42.62M 2023-12
Intuitive Surgical USD 15.44B 728.8M 2023-12
J&J USD 166.06B 25.62B 2023-09
Merck USD 106.73B 2.26B 2023-09
Merit Medical Systems USD 2.33B 516.74M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Stryker USD 39.88B 1.84B 2023-12
Tandem Diabetes Care USD 952.66M 12.75M 2023-12
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Zimmer Biomet Holdings USD 21.5B 279.6M 2023-12
Zoetis USD 14.29B 180M 2023-12



J&J 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.